AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 7931090 — intervention group
Group type: EXPERIMENTAL
Intervention: Auditory processing of verbal material (Task 1)
Number of subjects: 0
Study 7931090 — intervention group
Group type: EXPERIMENTAL
Intervention: Processing of emotions shown on faces (Task 2)
Number of subjects: 0
Study 7931090 — intervention group
Group type: EXPERIMENTAL
Intervention: Processing of visual categorical and coordinate spatial relations (Task 3)
Number of subjects: 0
Study 7931090 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual processing of verbal material (Task 4)
Number of subjects: 0
Study 2896471 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 80
Study 2896471 — intervention group
Group type: COMPARATOR
Intervention: Thiopentone
Number of subjects: 80
Study 29358446 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast track initiation counselling for patients eligible for antiretroviral therapy (ART)
Number of subjects: 3456
Study 29358446 — intervention group
Group type: EXPERIMENTAL
Intervention: Adherence clubs for stable ART patients
Number of subjects: 3456
Study 29358446 — intervention group
Group type: EXPERIMENTAL
Intervention: Decentralised medication delivery for stable ART patients
Number of subjects: 3456
Study 29358446 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced adherence counselling for unstable ART patients
Number of subjects: 3456
Study 29358446 — intervention group
Group type: EXPERIMENTAL
Intervention: Early tracing of patients who miss an appointment by ≥5 days
Number of subjects: 3456
Study 29358446 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (comparison clinics)
Number of subjects: 3456
Study 27249416 — intervention group
Group type: EXPERIMENTAL
Intervention: Albumin-adjusted serum anion gap (A-SAG)
Number of subjects: 440
Study 27249416 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 440
Study 26235790 — intervention group
Group type: EXPERIMENTAL
Intervention: Icare PRO
Number of subjects: 50
Study 26235790 — intervention group
Group type: COMPARATOR
Intervention: Tono-Pen
Number of subjects: 50
Study 23034128 — intervention group
Group type: EXPERIMENTAL
Intervention: Phyllanthus
Number of subjects: 60
Study 23034128 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 21076158 — intervention group
Group type: EXPERIMENTAL
Intervention: AAD treatment for the first 6 weeks after ablation
Number of subjects: 110
Study 21076158 — intervention group
Group type: COMPARATOR
Intervention: No AAD treatment for the first 6 weeks after ablation
Number of subjects: 110
Study 21076158 — intervention group
Group type: EXPERIMENTAL
Intervention: Early AF recurrence (on or off AADs) during the initial 6-week period
Number of subjects: 110
Study 18215983 — intervention group
Group type: EXPERIMENTAL
Intervention: Protease inhibitor dose escalation in response to therapeutic drug monitoring (TDM) with an inhibitory quotient
Number of subjects: 0
Study 18215983 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 16813838 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioural intervention programme
Number of subjects: 710
Study 16813838 — intervention group
Group type: COMPARATOR
Intervention: Usual care control group
Number of subjects: 710
Study 14614766 — intervention group
Group type: EXPERIMENTAL
Intervention: Leucocyte IFNalpha 3MU three times weekly plus ribavirin
Number of subjects: 423
Study 14614766 — intervention group
Group type: COMPARATOR
Intervention: Recombinant IFNalpha-2b plus ribavirin
Number of subjects: 423
Study 14614766 — intervention group
Group type: EXPERIMENTAL
Intervention: Leucocyte IFNalpha plus ribavirin
Number of subjects: 423
Study 15493484 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured preparatory information provided by operating room nurses
Number of subjects: 60
Study 15493484 — intervention group
Group type: COMPARATOR
Intervention: Uninformed patients
Number of subjects: 60
Study 10421233 — intervention group
Group type: EXPERIMENTAL
Intervention: gliclazide
Number of subjects: 36
Study 10421233 — intervention group
Group type: COMPARATOR
Intervention: metformin
Number of subjects: 36
Study 8532490 — intervention group
Group type: COMPARATOR
Intervention: Familiarization with either the first (target) or the second (distractor) or both odors from a pair, with varying numbers of familiarization sessions (one, two, or three).
Number of subjects: 0
Study 8532490 — intervention group
Group type: EXPERIMENTAL
Intervention: Familiarization with odors (target, distractor, or both).
Number of subjects: 0
Study 2319467 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg nicotine gum
Number of subjects: 78
Study 2319467 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg nicotine gum
Number of subjects: 78
Study 2319467 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 mg nicotine gum
Number of subjects: 78
Study 2319467 — intervention group
Group type: COMPARATOR
Intervention: 0 mg nicotine gum
Number of subjects: 78
Study 2319467 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher doses (2 mg and 4 mg)
Number of subjects: 78
Study 493904 — intervention group
Group type: COMPARATOR
Intervention: Cool, dry room air (CDA) at 23 degrees C with 3 mg of water and 7.3 cal of heat content/l
Number of subjects: 5
Study 493904 — intervention group
Group type: COMPARATOR
Intervention: Over-saturated air (OSA) at room temperature containing 43 mg water and 16.3 cal/l
Number of subjects: 5
Study 493904 — intervention group
Group type: EXPERIMENTAL
Intervention: Warm, humidified air (WHA) at 37 degrees C with 43 mg water and 34.7 cal/l
Number of subjects: 5
Study 493904 — intervention group
Group type: EXPERIMENTAL
Intervention: Hot, dry air (HDA) at 120 degrees C having 3 mg water and 24.4 cal/l
Number of subjects: 5
Study 31478892 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl (time-weighted cumulative dose above the median)
Number of subjects: 70
Study 31478892 — intervention group
Group type: COMPARATOR
Intervention: No fentanyl
Number of subjects: 70
Study 27926528 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine (sub-anesthetic dose of racemic ketamine hydrochloride)
Number of subjects: 42
Study 27926528 — intervention group
Group type: COMPARATOR
Intervention: Midazolam
Number of subjects: 42
Study 25439678 — intervention group
Group type: EXPERIMENTAL
Intervention: Foster care intervention
Number of subjects: 136
Study 25439678 — intervention group
Group type: COMPARATOR
Intervention: Care-as-usual
Number of subjects: 136
Study 23566636 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose B vitamin therapy
Number of subjects: 3673
Study 23566636 — intervention group
Group type: COMPARATOR
Intervention: Low-dose B vitamin therapy
Number of subjects: 3673
Study 23566636 — intervention group
Group type: EXPERIMENTAL
Intervention: Low eGFR (<45 mL/min/1.73 m²)
Number of subjects: 3673
Study 21627339 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab (10 mg/kg) plus Interferon-α (9 MIU)
Number of subjects: 0
Study 21627339 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab (10 mg/kg) plus Interferon-α (6 MIU)
Number of subjects: 0
Study 21627339 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab (10 mg/kg) plus Interferon-α (3 MIU)
Number of subjects: 0
Study 21627339 — intervention group
Group type: COMPARATOR
Intervention: Sunitinib (50 mg)
Number of subjects: 0
Study 19407523 — intervention group
Group type: EXPERIMENTAL
Intervention: Dilapan-S
Number of subjects: 0
Study 19407523 — intervention group
Group type: EXPERIMENTAL
Intervention: Lamicel
Number of subjects: 0
Study 19407523 — intervention group
Group type: COMPARATOR
Intervention: Laminaria
Number of subjects: 0
Study 19407523 — intervention group
Group type: EXPERIMENTAL
Intervention: Misoprostol
Number of subjects: 0
Study 18042575 — intervention group
Group type: EXPERIMENTAL
Intervention: pegylated-interferon alpha (PEG-2a) plus ribavirin (RV)
Number of subjects: 0
Study 18042575 — intervention group
Group type: EXPERIMENTAL
Intervention: pegylated-interferon alpha (PEG-2a) monotherapy
Number of subjects: 0
Study 18042575 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study 16035641 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP)
Number of subjects: 14
Study 16035641 — intervention group
Group type: COMPARATOR
Intervention: Control group (no PRP)
Number of subjects: 14
Study 11708311 — intervention group
Group type: EXPERIMENTAL
Intervention: Soybean oil-based preparation of CoQ10 (300 mg daily for 7 days)
Number of subjects: 12
Study 11708311 — intervention group
Group type: EXPERIMENTAL
Intervention: Complex micelle emulsion of CoQ10 (300 mg daily for 7 days)
Number of subjects: 12
Study 11708311 — intervention group
Group type: COMPARATOR
Intervention: Both preparations of CoQ10
Number of subjects: 12
Study 9149124 — intervention group
Group type: EXPERIMENTAL
Intervention: Carboplatin (CBDCA) administered 10 min after achieving target temperature (41.8 degrees C) during the plateau phase of WBH
Number of subjects: 17
Study 9149124 — intervention group
Group type: COMPARATOR
Intervention: Carboplatin (CBDCA) administered on an early schedule before reaching target temperature
Number of subjects: 17
Study 9149124 — intervention group
Group type: EXPERIMENTAL
Intervention: Ifosfamide, etoposide, and granulocyte colony stimulating factor delivered during all cycles
Number of subjects: 17
Study 8189742 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate dose of alcohol
Number of subjects: 0
Study 8189742 — intervention group
Group type: COMPARATOR
Intervention: Tonic water
Number of subjects: 0
Study 8189742 — intervention group
Group type: EXPERIMENTAL
Intervention: Belief of having consumed alcohol
Number of subjects: 0
Study 8189742 — intervention group
Group type: COMPARATOR
Intervention: Belief of having consumed tonic water
Number of subjects: 0
Study 30027292 — intervention group
Group type: EXPERIMENTAL
Intervention: C-509T allele in TGFB1 gene
Number of subjects: 287
Study 30027292 — intervention group
Group type: COMPARATOR
Intervention: No C-509T allele in TGFB1 gene
Number of subjects: 287
Study 26580349 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacist intervention (n=26)
Number of subjects: 213
Study 26580349 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=25)
Number of subjects: 213
Study 25282112 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin treatment in PCOS women
Number of subjects: 0
Study 25282112 — intervention group
Group type: COMPARATOR
Intervention: Exercise intervention
Number of subjects: 0
Study 23556486 — intervention group
Group type: EXPERIMENTAL
Intervention: Tapered-shaped polyvinylchloride cuff
Number of subjects: 60
Study 23556486 — intervention group
Group type: COMPARATOR
Intervention: Barrel-shaped polyvinylchloride cuff (Control)
Number of subjects: 60
Study 20514951 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin 1200 mg preoperatively, then 600 mg twice a day for two days postoperatively
Number of subjects: 60
Study 20514951 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 20514951 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin
Number of subjects: 60
Study 19037955 — intervention group
Group type: EXPERIMENTAL
Intervention: Postural experiences
Number of subjects: 42
Study 19037955 — intervention group
Group type: EXPERIMENTAL
Intervention: Object-oriented experiences
Number of subjects: 42
Study 19037955 — intervention group
Group type: COMPARATOR
Intervention: Social experiences (control)
Number of subjects: 42
Study 17238301 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-aided diabetes education
Number of subjects: 19
Study 14714361 — intervention group
Group type: EXPERIMENTAL
Intervention: Fuzheng Yiliu Granule (FZYLG) for 15 days
Number of subjects: 76
Study 10799426 — intervention group
Group type: EXPERIMENTAL
Intervention: Salbutamol (200 microg three times daily)
Number of subjects: 80
Study 10799426 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 10799426 — intervention group
Group type: EXPERIMENTAL
Intervention: Salbutamol (400 microg)
Number of subjects: 80
Study 8798121 — intervention group
Group type: EXPERIMENTAL
Intervention: Carotid and vertebral artery transluminal angioplasty
Number of subjects: 193
Study 8798121 — intervention group
Group type: COMPARATOR
Intervention: Carotid endarterectomy
Number of subjects: 193
Study 8798121 — intervention group
Group type: COMPARATOR
Intervention: Best medical treatment
Number of subjects: 193
Study 1461540 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin
Number of subjects: 0
Study 1461540 — intervention group
Group type: COMPARATOR
Intervention: Gemfibrozil
Number of subjects: 0
Study 2857061 — intervention group
Group type: EXPERIMENTAL
Intervention: Special Intervention (SI) program
Number of subjects: 12866
Study 2857061 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 12866
Study 30267937 — intervention group
Group type: EXPERIMENTAL
Intervention: Reproductive Life Plan (RLP) tool-based information
Number of subjects: 181
Study 30267937 — intervention group
Group type: COMPARATOR
Intervention: Control group 1 (CG1)
Number of subjects: 181
Study 30267937 — intervention group
Group type: COMPARATOR
Intervention: Control group 2 (CG2)
Number of subjects: 181
Study 27887605 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin glargine
Number of subjects: 162
Study 27887605 — intervention group
Group type: COMPARATOR
Intervention: NPH insulin
Number of subjects: 162
Study 24172145 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioural Activation (BA)
Number of subjects: 100
Study 24172145 — intervention group
Group type: COMPARATOR
Intervention: Antidepressant Medication (ADM)
Number of subjects: 100
Study 22669133 — intervention group
Group type: EXPERIMENTAL
Intervention: vShield device
Number of subjects: 23
Study 22669133 — intervention group
Group type: COMPARATOR
Intervention: Medical therapy
Number of subjects: 23
Study 19578227 — intervention group
Group type: EXPERIMENTAL
Intervention: LED phototherapy
Number of subjects: 272
Study 19578227 — intervention group
Group type: COMPARATOR
Intervention: CFT phototherapy
Number of subjects: 272
Study 18554731 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (200mg)
Number of subjects: 0
Study 18554731 — intervention group
Group type: EXPERIMENTAL
Intervention: Napping (60-90min)
Number of subjects: 0
Study 18554731 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 15981783 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective skin cooling over m. vastus lateralis (VL) for 3 min before resting mfMRI and MVC tests, and before, during, and after KEE
Number of subjects: 7
Study 15981783 — intervention group
Group type: COMPARATOR
Intervention: No skin cooling (control)
Number of subjects: 7
Study 12117831 — intervention group
Group type: EXPERIMENTAL
Intervention: Early moderate to severe mitral regurgitation
Number of subjects: 757
Study 12117831 — intervention group
Group type: EXPERIMENTAL
Intervention: Left ventricular thrombosis
Number of subjects: 757
Study 10407233 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment exposure (dose)
Number of subjects: 0
Study 10407233 — intervention group
Group type: COMPARATOR
Intervention: Control group responses
Number of subjects: 0
Study 10407233 — intervention group
Group type: EXPERIMENTAL
Intervention: Random effects model
Number of subjects: 0
Study 10407233 — intervention group
Group type: EXPERIMENTAL
Intervention: Bootstrap procedure
Number of subjects: 0
Study 7770495 — intervention group
Group type: EXPERIMENTAL
Intervention: Multichannel functional electrical stimulation (MFES) followed by conventional therapy
Number of subjects: 20
Study 7770495 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy followed by multichannel functional electrical stimulation (MFES)
Number of subjects: 20
Study 2182604 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentostatin
Number of subjects: 0
Study 2182604 — intervention group
Group type: EXPERIMENTAL
Intervention: Splenectomy
Number of subjects: 0
Study 2182604 — intervention group
Group type: EXPERIMENTAL
Intervention: Alpha-interferon
Number of subjects: 0
Study 375722 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment for mild hypertension
Number of subjects: 22700
Study 30758261 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet for 4 days
Number of subjects: 11
Study 30758261 — intervention group
Group type: COMPARATOR
Intervention: Western diet for 4 days
Number of subjects: 11
Study 30058184 — intervention group
Group type: EXPERIMENTAL
Intervention: Outpatient multidisciplinary therapy (36 weeks)
Number of subjects: 22
Study 30058184 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 22
Study 27292817 — intervention group
Group type: EXPERIMENTAL
Intervention: levomilnacipran ER
Number of subjects: 2598
Study 24703170 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjunctive medroxyprogesterone acetate (MPA)
Number of subjects: 51
Study 24703170 — intervention group
Group type: COMPARATOR
Intervention: Adjunctive placebo
Number of subjects: 51
Study 24703170 — intervention group
Group type: COMPARATOR
Intervention: Adjunctive tamoxifen
Number of subjects: 51
Study 22018458 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistive vibration exercise (RVE)
Number of subjects: 20
Study 22018458 — intervention group
Group type: COMPARATOR
Intervention: Inactive control group
Number of subjects: 20
Study 20401702 — intervention group
Group type: EXPERIMENTAL
Intervention: Exclusive breast feeding (Group 1, n=26)
Number of subjects: 52
Study 20401702 — intervention group
Group type: COMPARATOR
Intervention: Fortified breast feeding (Group 2, n=26)
Number of subjects: 52
Study 18076273 — intervention group
Group type: COMPARATOR
Intervention: Multiple Sets (MS; n = 18)
Number of subjects: 40
Study 18076273 — intervention group
Group type: EXPERIMENTAL
Intervention: Single Set (SS; n = 14)
Number of subjects: 40
Study 18076273 — intervention group
Group type: COMPARATOR
Intervention: Control (C; n = 8)
Number of subjects: 40
Study 16150765 — intervention group
Group type: EXPERIMENTAL
Intervention: Social behaviour and network therapy
Number of subjects: 742
Study 16150765 — intervention group
Group type: COMPARATOR
Intervention: Motivational enhancement therapy
Number of subjects: 742
Study 16150765 — intervention group
Group type: EXPERIMENTAL
Intervention: Both therapies
Number of subjects: 742
Study 12582946 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute moderate hypoxia (H)
Number of subjects: 8
Study 12582946 — intervention group
Group type: COMPARATOR
Intervention: Normoxia (N)
Number of subjects: 8
Study 10492489 — intervention group
Group type: EXPERIMENTAL
Intervention: Community pharmacist intervention (education about cardiovascular risk factors, point-of-care cholesterol test, physician contact form)
Number of subjects: 1000
Study 10492489 — intervention group
Group type: COMPARATOR
Intervention: Usual care (brochure only, minimal follow-up)
Number of subjects: 1000
Study 8621843 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (FP) 200 micrograms daily
Number of subjects: 240
Study 8621843 — intervention group
Group type: COMPARATOR
Intervention: Loratadine 10 mg daily
Number of subjects: 240
Study 2009156 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 6356688 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefazolin plus metronidazole
Number of subjects: 59
Study 6356688 — intervention group
Group type: COMPARATOR
Intervention: Cefazolin
Number of subjects: 59
Study 30685106 — intervention group
Group type: EXPERIMENTAL
Intervention: Group psychotherapy (n = 15)
Number of subjects: 25
Study 30685106 — intervention group
Group type: COMPARATOR
Intervention: No psychotherapy (control group, n = 10)
Number of subjects: 25
Study 27863126 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline weight
Number of subjects: 623
Study 27863126 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline perceived weight status
Number of subjects: 623
Study 25953940 — intervention group
Group type: EXPERIMENTAL
Intervention: 3% saline compresses (Group A) 3 times weekly
Number of subjects: 78
Study 25953940 — intervention group
Group type: COMPARATOR
Intervention: Mupirocine 2% ointment (Group B) 3 times weekly
Number of subjects: 78
Study 25953940 — intervention group
Group type: COMPARATOR
Intervention: No aseptic agents (Group C)
Number of subjects: 78
Study 23792806 — intervention group
Group type: EXPERIMENTAL
Intervention: Elicited pantomime
Number of subjects: 0
Study 21352390 — intervention group
Group type: EXPERIMENTAL
Intervention: 12C (4 mm tip ablation catheter with 12 irrigation channels, 6 distal and 6 proximal)
Number of subjects: 95
Study 21352390 — intervention group
Group type: COMPARATOR
Intervention: 6C (3.5 mm tip ablation catheter with 6 distal irrigation channels)
Number of subjects: 95
Study 21352390 — intervention group
Group type: EXPERIMENTAL
Intervention: 12C
Number of subjects: 95
Study 21352390 — intervention group
Group type: COMPARATOR
Intervention: 6C
Number of subjects: 95
Study 19962601 — intervention group
Group type: EXPERIMENTAL
Intervention: Facial sensory-retraining exercises with standard opening exercises
Number of subjects: 186
Study 19962601 — intervention group
Group type: COMPARATOR
Intervention: Standard opening exercises only
Number of subjects: 186
Study 17178976 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose quadruple antihypertensive combination (4 agents at one-quarter dosage; n=22)
Number of subjects: 108
Study 17178976 — intervention group
Group type: COMPARATOR
Intervention: Amlodipine (5 mg; n=22)
Number of subjects: 108
Study 17178976 — intervention group
Group type: COMPARATOR
Intervention: Atenolol (50 mg; n=20)
Number of subjects: 108
Study 17178976 — intervention group
Group type: COMPARATOR
Intervention: Bendroflumethiazide (2.5 mg; n=22)
Number of subjects: 108
Study 17178976 — intervention group
Group type: COMPARATOR
Intervention: Captopril (50 mg twice daily; n=22)
Number of subjects: 108
Study 17178976 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose quadruple antihypertensive combination
Number of subjects: 108
Study 17178976 — intervention group
Group type: COMPARATOR
Intervention: Individual drugs (Amlodipine, Atenolol, Bendroflumethiazide, Captopril)
Number of subjects: 108
Study 15595229 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical ketoprofen 20% in a poloxamer-lecithin organogel (PLO)
Number of subjects: 8
Study 15595229 — intervention group
Group type: COMPARATOR
Intervention: Oral 50-mg ketoprofen capsule
Number of subjects: 8
Study 10802278 — intervention group
Group type: EXPERIMENTAL
Intervention: Nestorone alone (50, 75, 100 µg daily over 6 months)
Number of subjects: 169
Study 10802278 — intervention group
Group type: EXPERIMENTAL
Intervention: ethinyl estradiol: Nestorone (30:100 and 15:150 µg daily over 6 months)
Number of subjects: 169